TargetMol

alpha-Viniferin

Product Code:
 
TAR-TN1378
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-TN1378-5mg5mg£337.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN1378-1mL1 mL * 10 mM (in DMSO)£1,556.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Alpha-viniferin is a prostaglandin H2 synthase inhibitor, which has anti-inflammatory, anti-oxidant, anti-arthritis, and anti-tumor activities.
CAS:
62218-13-7
Formula:
C42H30O9
Molecular Weight:
678.693
Pathway:
GPCR/G Protein; Metabolism; Immunology/Inflammation;
Purity:
0.98
SMILES:
[H][C@]12[C@@H](Oc3cc(O)cc(c13)[C@]1([H])[C@H](Oc3cc(O)cc(c13)[C@@]1([H])[C@@H](Oc3cc(O)cc2c13)c1ccc(O)cc1)c1ccc(O)cc1)c1ccc(O)cc1
Target:
P45; Prostaglandin Receptor

References

Lee JY, et al. alpha-Viniferin suppresses the signal transducer and activation of transcription-1 (STAT-1)-inducible inflammatory genes in interferon-gamma-stimulated macrophages.J Pharmacol Sci. 2010;112(4):405-14. Fan Y, et al. Pharmacokinetic and bioavailability studies of ?-viniferin after intravenous and oral administration to rats. J Pharm Biomed Anal. 2020 Sep 5;188:113376. Sim J, et al. Potent inhibitory effect of alpha-viniferin on human cytochrome P450. Food Chem Toxicol. 2014 Jul;69:276-80. Seo H, et al. In vitro activity of alpha-viniferin isolated from the roots of Carex humilis against Mycobacterium tuberculosis. Pulm Pharmacol Ther. 2017 Oct;46:41-47.